Literature DB >> 17312825

Low molecular weight heparin prophylaxis in day case surgery.

J Shabbir1, P F Ridgway, W Shields, D Evoy, J B O'Mahony, K Mealy.   

Abstract

BACKGROUND: The role of Low molecular weight heparins (LMWH) in day case/short-stay surgery is unknown. AIM: To characterise the current national use of LMWH prophylaxis in specific day and short stay surgeries.
METHODS: A standardised anonymous postal questionnaire was sent to all consultant general surgeons in Ireland. The operations selected were herniorraphy, anorectal, varicose vein and laparoscopic cholecystectomy.
RESULTS: Questionnaires were sent to 82 surgeons in 2003. There was a response rate of 68.3% (56). Fifty-four per cent of respondents said there was a protocol in place for administration of LMWH in day case surgery. Of these 41% were not confident that their protocols were being adhered. Fifty-nine per cent of all respondents said they stratified patients according to individual risk. Thirteen per cent reported occurrence of VTE post day case surgery
CONCLUSION: This study demonstrates a heterogeneous pattern of administration of LMWH. In the absence of published validated protocols, the authors suggest a consensus day case protocol.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17312825     DOI: 10.1007/bf03167963

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  9 in total

1.  Prevention of venous thromboembolism in Wales: results of a survey among general surgeons.

Authors:  E V Williams; R S Williams; J L Hughes; K L Williams; M E Foster; M H Lewis
Journal:  Postgrad Med J       Date:  2002-02       Impact factor: 2.401

Review 2.  Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.

Authors: 
Journal:  BMJ       Date:  1992-09-05

3.  Unfractionated heparin, time for a change?

Authors:  P F Ridgway; J Crosbie; K A Hinedi; W Ghadban; A Kelly; R O'Donnell; J Hollingsworth
Journal:  Ir Med J       Date:  1999-04

4.  Thromboembolism prophylaxis during laparoscopic cholecystectomy.

Authors:  A W Bradbury; Y C Chan; A Darzi; G Stansby
Journal:  Br J Surg       Date:  1997-07       Impact factor: 6.939

5.  Postoperative thromboembolism after day-case herniorrhaphy.

Authors:  C Riber; N Alstrup; T Nymann; J W Bogstad; P Wille-Jørgensen; H Tønnesen
Journal:  Br J Surg       Date:  1996-03       Impact factor: 6.939

6.  Still missing the boat with fatal pulmonary embolism.

Authors:  T E Gillies; C V Ruckley; S J Nixon
Journal:  Br J Surg       Date:  1996-10       Impact factor: 6.939

7.  Prediction and selective prophylaxis of venous thrombosis in elective gastrointestinal surgery.

Authors:  G D Lowe; D H Osborne; B M McArdle; A Smith; D C Carter; C D Forbes; D McLaren; C R Prentice
Journal:  Lancet       Date:  1982-02-20       Impact factor: 79.321

8.  Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis.

Authors:  M T Nurmohamed; F R Rosendaal; H R Büller; E Dekker; D W Hommes; J P Vandenbroucke; E Briët
Journal:  Lancet       Date:  1992-07-18       Impact factor: 79.321

Review 9.  Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis.

Authors:  G P Clagett; J S Reisch
Journal:  Ann Surg       Date:  1988-08       Impact factor: 12.969

  9 in total
  3 in total

1.  Slow femoral venous flow and venous thromboembolism following inguinal hernioplasty in patients without or with low molecular weight heparin prophylaxis.

Authors:  F S Lozano; J Sánchez-Fernández; J R González-Porras; J García-Alovio; J A Santos; R Mateos; I Alberca
Journal:  Hernia       Date:  2015-02-08       Impact factor: 4.739

Review 2.  Perioperative Management of the Ambulatory Anorectal Surgery Patient.

Authors:  Darcy Shaw; Charles A Ternent
Journal:  Clin Colon Rectal Surg       Date:  2016-03

3.  Identifying patients at high risk for venous thromboembolism requiring treatment after outpatient surgery.

Authors:  Christopher J Pannucci; Amy Shanks; Marc J Moote; Vinita Bahl; Paul S Cederna; Norah N Naughton; Thomas W Wakefield; Peter K Henke; Darrell A Campbell; Sachin Kheterpal
Journal:  Ann Surg       Date:  2012-06       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.